Prospective, Post Marketing Surveillance of RECTABUL2mg rectal form
Latest Information Update: 18 Feb 2022
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors EA Pharma; Kissei Pharmaceutical
- 17 Feb 2022 Status changed from recruiting to completed.
- 01 Aug 2021 Interim Results (n=182) evaluating safety, efficacy and acceptance of Budesonide foam in patients with ulcerative-colitis, published in the Expert Opinion on Pharmacotherapy
- 14 Feb 2018 New trial record